v3.26.3
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Warrants Activity

A summary of activity regarding warrants to purchase common stock (excluding pre-funded warrants) for the six months ended June 30, 2026 were as follows:

 

   Number of   Weighted-Average   Average 
   Warrants   Exercise Price   Life (years) 
Outstanding, December 31, 2025   13,689   $376.20    3.72 
Granted   927,185    10.30    2.85 
Outstanding, June 30, 2026   940,874   $15.61    2.85 
Schedule of Restricted Stock Units (RSUs)

The following is a summary of activity regarding Restricted Stock Units issued:

 

   Number of RSU  

Weighted-Average

Fair Value Per RSU

 
Outstanding, December 31, 2025   15,167   $52.80 
Forfeited   (3,415)   48.80 
Vested   (4,480)   53.76 
Outstanding, June 30, 2026   7,272   $53.81 
Schedule of Compensation Expenses (RSUs)

Stock-based compensation expense related to RSUs was classified as follows for the three and six months ended June 30, 2026 and 2025:

 

   2026   2025   2026   2025 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2026   2025   2026   2025 
Research and development  $823   $1,111   $2,507   $321,215 
General and administrative   (8,334)   45,742    25,000    262,684 
Total  $(7,511)  $46,853   $27,507   $583,899 
Schedule of Weighted Average Grant Date Fair Value of Stock Options Granted

The following weighted-average assumptions were used in estimating the grant-date fair value of stock options granted during the six months ended June 30, 2026:

 

Dividend Yield   0%
Expected Life (Years)   5.63 Years 
Risk-free rate of interest for expected life   3.97%
Volatility   113%
Stock Price  $7.80 
Strike Price  $7.350 
Schedule of Option Activity

The following table summarizes stock option activity for the six months ended June 30, 2026:

 

   Number of
Options
  

Weighted-Average

Exercise Price

  

Weighted-Average

Remaining

Contractual Term

  

Aggregate

Intrinsic Value

 
Outstanding at December 31, 2025   -    -             
Granted   444,799    7.35           
Outstanding at June 30, 2026   444,799    7.35    9.8       
Exercisable at June 30, 2026   -    -    -